PAS-004

N/A

Report date: 2025/05/30 10:17:16
NME

Base Information

Drug NamePAS-004
Drug Alias NameCIP-137401CIP-1374PAS-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 inhibitorsDual specificity mitogen-activated protein kinase kinase 2 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 2Dual specificity mitogen-activated protein kinase kinase 1
Therapy Area/IndicationsSolid tumoursCardiomyopathiesNeurofibromatosis 1 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesRomania +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCheminpharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesPasithea Therapeutics CorpColumbia University
Inactive CompaniesN/A
Active IndicationsSolid tumoursCardiomyopathiesNeurofibromatosis 1 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A